药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pergolide
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Bosutinib.
Pergolide
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Bosutinib.
Pergolide
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Bosutinib.
Pergolide
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Bosutinib.
Pergolide
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Bosutinib.
Pergolide
Brequinar
The risk or severity of adverse effects can be increased when Brequinar is combined with Bosutinib.
Pergolide
2-Methoxyethanol
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Bosutinib.
Pergolide
Vorinostat
The risk or severity of adverse effects can be increased when Vorinostat is combined with Bosutinib.
Pergolide
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Bosutinib.
Pergolide
Stepronin
The risk or severity of adverse effects can be increased when Stepronin is combined with Bosutinib.
Pergolide
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Bosutinib.
Pergolide
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Bosutinib.
Pergolide
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Bosutinib.
Pergolide
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Bosutinib.
Pergolide
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Bosutinib.
Fluoxymesterone
Givosiran
The serum concentration of Tafenoquine can be increased when it is combined with Givosiran.
Fluoxymesterone
Dalfampridine
The serum concentration of Dalfampridine can be increased when it is combined with Tafenoquine.
Fluoxymesterone
Emapalumab
The metabolism of Tafenoquine can be increased when combined with Emapalumab.
Fluoxymesterone
Siltuximab
The metabolism of Tafenoquine can be increased when combined with Siltuximab.
Fluoxymesterone
Secukinumab
The metabolism of Tafenoquine can be increased when combined with Secukinumab.